Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 465-466, 2004; 10.1373/clinchem.2003.029736
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bossuyt, P. M.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bossuyt, P. M.M.
Related Collections
Right arrow Evidence Based Laboratory Medicine and Test Utilization
(Clinical Chemistry. 2004;50:465-466.)
© 2004 American Association for Clinical Chemistry, Inc.


Editorial

The Quality of Reporting in Diagnostic Test Research: Getting Better, Still Not Optimal

Patrick M.M. Bossuyt1

1 Academic Medical Center, University of Amsterdam, Amsterdam, NA 1105 AZ The Netherlands, Fax 31-31-20-6912683, E-mail p.m.bossuyt@amc.uva.nl

The first 20% of the full text of this article appears below.

In this era of evidence-based medicine, clinicians and other decision-makers turn to the scientific literature for high-quality evidence about the usefulness, precision, and accuracy of diagnostic tests. Such evidence is needed more than ever because the list of diagnostic tests is growing exponentially, and even more biomarkers, proteomics, and applications of gene expression profiling will be added in the years to come.

Studies of diagnostic accuracy can provide the necessary data. Rigorous methodologic standards in research about diagnostic tests have been slower to develop than standards for therapy studies. During the past decade, our knowledge about study design features that are associated with bias and lack of applicability in diagnostic studies has grown. Diagnostic studies with deficiencies in specific design features have been shown to be associated with biased, optimistic estimates of diagnostic accuracy compared with studies without such deficiencies (1).

Given this potential for bias, it is of paramount importance that study reports include a proper description of the study methods, in particular those design features that have been most clearly associated with bias. Within the spirit of evidence-based medicine, readers should take these features into account when examining a study and its results, pondering the decision on whether to implement changes in practice based on conclusions from the study.

Unfortunately, the quality . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.